Modeling Age-Related Diseases in Drosophila: Can this Fly?

Current Topics in Developmental Biology

Volumn 71, Issue , 2005, Pages 199-223

  Michno, Kinga ^a,b   van de Hoef, Diana ^a,b   Wu, Hong ^a   Boulianne, Gabrielle L ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ANIMAL; BIOLOGICAL MODEL; DEGENERATIVE DISEASE; DISEASE MODEL; DROSOPHILA; GENETICS; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

AGING; ANIMALS; DISEASE MODELS, ANIMAL; DROSOPHILA; HUMANS; MODELS, GENETIC; NEURODEGENERATIVE DISEASES;

EID: 33646125425     PISSN: 00702153     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0070-2153(05)71006-1     Document Type: Review

References (107)

1. Apostol B.L., Kazantsev A., Raffioni S., Illes K., Pallos J., Bodai L., Slepko N., Bear J.E., Gertler F.B., Hersch S., Housman D.E., Marsh J.L., and Thompson L.M. A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila. Proc. Natl. Acad. Sci. USA 100 (2003) 5950-5955
2. Bates G., Harper P., and Jones L. "Huntington's Disease, 3rd edition" (2002), Oxford University Press, Oxford, UK
3. Boulianne G.L., Livne-Bar I., Humphreys J.M., Liang Y., Lin C., Rogaev E., and St. George-Hyslop P. Cloning and characterization of the Drosophila presenilin homologue. NeuroReport 8 (1997) 1025-1029
4. Brand A.H., and Dormand E.L. The GAL4 system as a tool for unravelling the mysteries of the Drosophila nervous system. Curr. Opin. Neurobiol. 5 (1995) 572-578
5. Brand A.H., and Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118 (1993) 401-415
6. Bruijn L.I., Houseweart M.K., Kato S., Aanderson K.L., Ohama E., Reaume A.G., Scott R.W., and Cleveland D.W. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281 (1998) 1851-1854
7. Davies S.W., Turmaine M., Cozens B.A., Di Figlia M., Sharp A.H., Ross C.A., Scherzinger E., Wanker E.E., Mangiarini L., and Bates G.P. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90 (1997) 537-548
8. DiFiglia M., Sapp E., Chase K.O., Davies S.W., Bates G.P., Vonsattel J.P., and Aronin N. Aggregation of huntintin in neuronal intranuclear inclusions and dystrophic neurites in the brain. Science 277 (1997) 1990-1993
9. Driscoll M., and Gerstbrein B. Dying for a cause: Invertebrate genetics takes on human neurodegeneration. Nat. Rev. Genet. 4 (2003) 181-194
10. Elia A.J., Parkes T.L., Kirby K., St. George-Hyslop P., Boulianne G.L., Phillips J.P., and Hilliker A.J. Expression of human FALS SOD in motorneurons of Drosophila. Free Rad. Biol. Med. 26 (1999) 1332-1338
11. Ellis M.C., O' Neill E.M., and Rubin G.M. Expression of Drosophila glass protein and evidence for negative regulation of its activity in non-neuronal cells by another DNA-binding protein. Development 119 (1993) 855-865
12. Faber P.W., Alter J.R., Mac Donald M.E., and Hart A.C. Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron. Proc. Natl. Acad. Sci. USA 96 (1999) 179-184
13. Feany M.B., and Bender W.W. A Drosophila model of Parkinson's disease. Nature 404 (2000) 394-398
14. Fernandez-Funez P., Nino-Rosales M.L., de Gouyon B., She W.-C., Luchak J.M., Martinez P., Turiegano E., Benito J., Capovilla M., Skinner P.J., McCall A., Canal I., Orr H.T., Zoghbi H.Y., and Botas J. Identification of genes that modify ataxin-1-induced neurodegeneration. Nature 408 (2000) 101-106
15. Finelli A., Kelkar A., Song HJ., Yang H., and Konsolaki M. A model for studying Alzheimer's A-beta 42-induced toxicity in Drosophila melanogaster. Mol. Cell. Neurosci. 26 (2004) 365-375
16. Fortini M.E., Skupski M.P., Boguski M.S., and Hariharan I.K. A survey of human disease gene counterparts in the Drosophila genome. J. Cell Biol. 150 (2000) F23-F29
17. Fossgreen A., Bruckner B., Czech C., Masters C.L., Beyreuther K., and Paro R. Transgenic Drosophila expressing human amyloid precursor protein show gamma-secretase activity and a blistered-wing phenotype. Proc. Natl. Acad. Sci. USA 95 (1998) 13703-13708
18. Goedert M., Spillantini M.G., Cairns N.J., and Crowther R.A. Tau proteins of Alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms. Neuron 8 (1992) 159-168
19. Goedert M., Wischik C.M., Crowther R.A., Walker J.E., and Klug A. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: Identification as the microtubule-associated protein tau. Proc. Natl. Acad. Sci. USA 85 (1988) 4051-4055
20. Greenberg S.G., and Davies P. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc. Natl. Acad. Sci. USA 87 (1990) 5827-5831
21. Greene J.C., Whitworth A.J., Kuo I., Andrews L.A., Feany M.B., and Pallanck L.J. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc. Natl. Acad. Sci. USA 100 (2003) 4078-4083
22. Greeve I., Kretzschmar D., Tschape JA., Beyn A., Brelllinger C., Schweizer M., Nitsch R.M., and Reifegerste R. Age-Dependent neurodegeneration and Alzheimer-Amyloid plaque formation in transgenic Drosophila. J. Neurosci. 24 (2004) 3899-3906
23. Group T.H.s.D.C.R. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72 (1993) 971-983
24. Gunawardena S., and Goldstein L.S.B. Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila. Neuron 32 (2001) 389-401
25. Guo Y., Livne-Bar I., Zhou L., and Boulianne G.L. Drosophila presenilin is required for neuronal differentiation and affects Notch subcellular localization and signaling. J. Neurosci. 19 (1999) 8435-8442
26. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentatii, Kwon Y.W., Deng H.-X., Chen W., Zhai P., Sufit R.L., and Siddique T. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase transgene. Science 264 (1994) 1772-1775
27. Gusella J.S., and Mac Donald M.E. Huntington's disease. Sem. Cell Biol. 6 (1995) 21-28
28. Gusella J.S., and Mac Donald M.E. Molecular genetics: Unmasking polyglutamine triggers in neurodegenerative diseases. Nat. Rev. Neurosci. 1 (2000) 109-115
29. Hebert L.E., Scherr P.A., Bienias J.L., Bennett D.A., and Evans D.A. Alzheimer Disease in the U.S. Population: Prevalance Estimates using the 2000 Census. Arch. Neurol 60 (2003) 1119-1122
30. Hockly E., Richon V.M., Woodman B., Smith D.L., Zhou X., Rosa E., Sathasivam K., Ghazi-Noori S., Mahal A., Lowden P.A., Steffan J.S., Marsh J.L., Thompson L.M., Lewis C.M., Marks P.A., and Bates G.P. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc. Natl. Acad. Sci. USA 100 (2003) 2041-2046
31. Hughes R.E. Polyglutamine disease: acetyltransferases awry. Curr. Biol. 12 (2002) R141-R143
32. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakraverty S., Isaacs A., Grover A., Hackett J., Adamson J., Lincoln S., Dickson D.W., Davies P., Petersen R.C., Stevens M., de Graaff E., Wauters E., and van Baren J. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393 (1998) 702-705
33. Iijima K., Liu H.P., Chiang A.S., Hearn S.A., Konsolaki M., and Zhong Y. Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: A potential model for Alzheimer's disease. Proc. Natl. Acad. Sci. USA 101 (2004) 6623-6628
34. Jackson G.R., Salecker I., Dong X., Yao X., Arnheim N., Faber P.W., Mac Donald M.E., and Zipursky S.L. Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron 21 (1998) 633-642
35. Jackson G.R., Wiedau-Paxos M., Sang T.K., Wagle N., Brown C.A., Massachi S., and Geschwind D.H. Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron 34 (2002) 509-519
36. Johnston J.A., Dalton M.J., Gurney M.E., and Kopito R.R.K. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 97 (2000) 12571-12576
37. Kang J., Lemaire H.G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.H., Multhaup G., Beyreuther K., and Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325 (1987) 733-736
38. Kauffmann R.C., Qian Y., Vogt A., Sebti S.M., Hamilton A.D., and Carthew R.W. Activated Drosophila Ras1 is selectively suppressed by isopropenyl transferase inhibitors. Proc. Natl. Acad. Sci. USA 92 (1995) 10919-10923
39. Kazantsev A., Preisinger E., Dranovsky A., Goldgaber D., and Housman D. Insoluble detergent-resistant aggregates form between pathological and non-pathological lengths of polyglutamine in mammalian cells. Proc. Natl. Acad. Sci. USA 96 (1999) 11404-11409
40. Kazemi-Esfarjani P., and Benzer S. Genetic suppression of polyglutamine toxicity in Drosophila. Science 287 (2000) 1837-1840
41. Kosik K.S., Orecchio L.D., Binder L., Trojanowski J.Q., Lee V.M., and Lee G. Epitopes that span the tau molecule are shared with paired helical filaments. Neuron 1 (1988) 817-825
42. Kraemer B.C., Zhang B., Leverenz J.B., Thomas J.H., Trojanowski J.Q., and Schellenberg G.D. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy. Proc. Natl. Acad. Sci. USA 100 (2003) 9980-9985
43. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Epplen J.T., Schols L., and Reiss O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18 (1998) 106-108
44. Kuebler D., and Tanouye M.A. Anticonvulsant valproate reduces seizure-susceptibility in mutant Drosophila. Brain Res. 958 (2002) 36-42
45. Lakso M., Vartiainen S., Moilanen A.M., Sirvio J., Thomas J.H., Nass R., Blakely R.D., and Wong G. Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human alpha-synuclein. J. Neurochem. 86 (2003) 165-172
46. Lee V.M., Balin B.J., Otvos Jr. L., and Trojanowski J.Q. A68: A major subunit of paired helical filaments and derivatized forms of normal Tau. Science 251 (1991) 675-678
47. Lee W.C., Yoshihara M., and Littleton J.T. Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease. Proc. Natl. Acad. Sci. USA 101 (2004) 3224-3229
48. Leissring M.A., Farris W., Chang A.Y., Walsh D.M., Wu X., Sun X., Frosch M.P., and Selkoe D.J. Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40 (2003) 1087-1093
49. Li S.H., Schilling G., Young III W.S., Li X.J., Margolis R.L., Stine O.C., Wagster M.V., Abbott M.H., Franz M.L., Ranen N.G., Folstein S.E., Hedreen J.C., and Ross C.A. Huntington's disease gene (IT15) is widely expressed in human and rat tissues. Neuron 11 (1993) 985-993
50. Link C.D., Johnson C.J., Fonte V., Paupard MC., Hall D.H., Styren S., Mathis C.A., and Klunk W.E. Visualization of fibrillar amyloid deposits in living, transgenic Caenorhabditis elegans animals using the sensitive amyloid dye, X-34. Neurobiol. Aging 22 (2001) 217-226
51. Lino M.M., Schneider C., and Caroni P. Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J. Neurosci. 22 (2002) 4825-4832
52. Luo L., Tully T., and White K. Human amyloid precursor protein ameliorates behavioral deficit of flies deleted for Appl gene. Neuron 9 (1992) 595-605
53. Macleod G.T., Hegstrom-Wojtowicz M., Charlton M.P., and Atwood H.L. Fast Calcium Signals in Drosophila Motorneuron terminals. J. Neurophys. 88 (2002) 2659-2663
54. Marsh J.L., Pallos J., and Thompson L.M. Fly models of Huntington's disease. Hum. Mol. Genet. 12 (2003) R187-R193
55. Marsh J.L., Walker H.A., Theisen H., Zhy Y.Z., Fielder T., Purcell J., and Thompson L.M. Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila. Hum. Mol. Genet. 9 (2000) 13-25
56. Mockett R.J., Radyuk S.N., Benes J.J., Orr W.C., and Sohal R.S. Phenotypic effects of familial amyotrophic lateral sclerosis mutant Sod alleles in transgenic Drosophila. Proc. Natl. Acad. Sci. USA 100 (2003) 301-306
57. Morley J.F., Brignull H.R., Weyers J.J., and Morimoto R.I. The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in. Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 99 (2002) 10417-10422
58. Nishimura I., Yang Y., and Lu B. PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in Drosophila. Cell 116 (2004) 671-682
59. Nucifora Jr. F.C., Sasaki M., Peters M.F., Huang H., Cooper J.K., Yamada M., Takahashi H., Tsuji S., Troncoso J., Dawson V.L., Dawson T.M., and Ross C.A. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291 (2001) 2423-2428
60. Oeda T., Shimohama S., Kitagawa N., Kohno R., Imura T., Shibasaki H., and Ishii N. Oxidative stress causes abnormal accumulation of familial amyotrophic lateral sclerosis-related mutant SOD1 in transgenic. Caenorhabditis elegans. Hum. Mol. Genet. 10 (2001) 2013-2023
61. Parker J.A., Connolly J.B., Wellington C., Hayden M., Dausset J., and Neri C. Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death. Proc. Natl. Acad. Sci. USA 98 (2001) 13318-13323
62. Parkes T.L., Elia A.J., Dickinson D., Hillier A.J., Phillips J.P., and Boulianne G.L. Extension of Drosophila lifespan by overexpression of human SOD1 in motorneurons. Nat. Genet. 19 (1998) 171-174
63. Paulson H.L. Protein fate in neurodegenerative proteinopathies: Polyglutamine disease joins the (mis)fold. Am. J. Hum. Genet. 64 (1999) 339-345
64. Penney J.B., Vonsattel J.P., Mac Donald M.E., Gusella J.S., and Myers R.H. CAG repeat number governs the rate of pathology in Huntington's disease. Ann. Neurol. 41 (1997) 689-692
65. Perutz M.F. Glutamine repeats and neurodegenerative diseases: Molecular aspects. Trends Biochem. Sci. 24 (1999) 58-63
66. Phillips J.P., Campbell S.D., Michaud D., Charbonneau M., and Hilliker A.J. Null mutation of copper/zinc superoxide dismutase in Drosophila confers hypersensitivity to paraquat and reduced longevity. Proc. Natl. Acad. Sci. USA 86 (1989) 2761-2765
67. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S.C., Athanassiadou A., Papepetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.U., and Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's Disease. Science 276 (1997) 2045-2047
68. Price D.L., Sisodia S.S., and Borchelt D.R. Genetic neurodegenerative diseases: The human illness and transgenic models. Science 282 (1998) 1079-1083
69. Price D.L., Tanzi R.E., Borchelt D.R., and Sisodia S.S. Alzheimer's disease: Genetic studies and transgenic models. Ann. Rev. Genet. 32 (1998) 461-493
70. Probst A., Langui D., and Ulrich J. Alzheimer's disease: a description of the structural lesions. Brain Pathol. 1 (1991) 229-239
71. Reaume A.G., Elliott J.L., Hoffman E.K., Kowall N.W., Ferrante R.J., Siwek D.F., Wilcox H.M., Flood D.G., Beal M.F., Brown Jr. R.H., Scott R.W., and Snider W.D. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat. Genet. 13 (1996) 43-47
72. Reiter L.T., Potocki L., Chien S., Gribskov M., and Bier E. A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster. Gen. Res. 11 (2001) 1114-1125
73. Reveillaud I., Phillips J.P., Duyf B., Hilliker A.J., Kongpachith A., and Fleming J.E. Phenotypic rescue of a bovine transgene in a Cu/Zn superoxide dismutase-null mutant of Drosophila melanogaster. Mol. Cell. Biol. 14 (1994) 1302-1307
74. Reynolds E.R., Stauffer E.A., Feeney L., Rojahn E., Jacobs B., and McKeever C. Treatment with the antiepileptic drugs phenytoin and gabapentin ameliorates seizure and paralysis of Drosophila bang-sensitve mutants. J. Neurobiol. 58 (2003) 504-513
75. Rival T., Soustelle L., Strambi C., Besson M.T., Iche M., and Birman S. Decreasing glutamate buffering capacity triggers oxidative stress and neuropil degeneration in the Drosophila brain. Curr. Biol. 14 (2004) 599-605
76. Robinow S., and White K. The locus elav of Drosophila melanogaster is expressed in neurons at all developmental stages. Dev. Biol. 126 (1988) 294-303
77. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O' Regan J.P., Deng H.-X., Rahmani Z., Krizus A., McKenna-Yasek D., Cayabyab A., Gaston S.M., Berger R., Tanzi R.E., Halperin J.J., Herzfeldt B., and Van de Bergh R. Mutations in Cu/Zn superoxide dismutatse gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (1993) 59-62
78. Rothstein J.D., Martin L.J., and Kuncl R.W. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N. Engl. J. Med. 326 (1992) 1464-1468
79. Rothstein J.D., Van Kammen M., Levey A.I., Martin L.J., and Kuncl R.W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38 (1995) 73-84
80. Rubin G.M., Yandell M.D., Wortman J.R., Gabor Miklos G.L., Nelson C.R., Hariharan I.K., Fortini M.E., Li P.W., Apweiler R., Fleischmann W., Cherry J.M., Henikoff S., Skupski M.P., Misra S., Ashburner M., Birney E., Boguski M.S., Brody T., Brokstein P., and Celniker S.E. Comparative genomics of the eukaryotes. Science 287 (2000) 2204-2215
81. Satyal S.H., Schmidt E., Kitagawa K., Sondheimer N., Lindquist S., Kramer J.M., and Morimoto R.I. Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 97 (2000) 5750-5755
82. Selkoe D.J. Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease. Ann. Rev. Cell Biol. 10 (1994) 373-403
83. Shimura H., Hattori N., Kubo S., Mizuno Y., Asakawa S., Minoshima S., Shimizu N., Iwai K., Chiba T., Tanaka K., and Suzuki T. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet. 25 (2000) 302-305
84. Shulman J.M., and Feany M.B. Genetic modifiers of tauopathy in Drosophila. Genetics 165 (2003) 1233-1242
85. Sisodia S.S., and St. George-Hyslop P. gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in?. Nat. Rev. Neurosci. 3 (2002) 281-290
86. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., and Goedert M. Alpha-synuclein in Lewy bodies. Nature 388 (1997) 839-840
87. Steffan J.S., Agrawal N., Pallos J., Rockabrand E., Trotman L.C., Slepko N., Illes K., Lukacsovich T., Zhu Y.Z., Cattaneo E., Pandolfi P.P., Thompson L.M., and Marsh J.L. SUMO modification of Huntingtin and Huntington's disease pathology. Science 304 (2004) 100-104
88. Steffan J.S., Bodai L., Pallos J., Poelman M., McCampbell A., Apostol B.L., Kazantsev A., Schmidt E., Zhu Y.Z., Greewald M., Kurokawa R., Housman D.E., Jackson G.R., Marsh J.L., and Thompson L.M. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413 (2001) 739-743
89. Steffan J.S., Kazantsev A., Spasic-Boskovic O., Greenwald M., Zhu Y.Z., Gohler H., Wanker E.E., Bates G.P., Housman D.E., and Thompson L.M. The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc. Natl. Acad. Sci. USA 97 (2000) 6763-6768
90. Strong T.V., Tagle D.A., Valdes J.M., Elmer L.W., Boehm K., Swaroop M., Kaatz K.W., Collins F.S., and Albin R.L. Widespread expression of human and rat Huntington's disease gene in brain and nonneuronal tissue. Nat. Genet. 5 (1993) 259-265
91. Struhl G., and Greenwald I. Presenilin is required for activity and nuclear access of Notch in Drosophila. Nature 398 (1999) 522-525
92. Takeyama K., Ito S., Yamamoto A., Tanimoto H., Furutani T., Kanuka H., Miura M., Tabata T., and Kato S. androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila. Neuron 35 (2002) 855-864
93. Tan J.S., Lin F., and Tanouye M.A. Potassium bromide, an anticonvulsant, is effective at alleviating seizures in the Drosophila bang-sensitive mutant bang senseless. Brain Res. 1020 (2004) 45-52
94. Torroja L., Packard M., Gorczyca M., White K., and Budnik V. The Drosophila beta-amyloid precursor protein homolog promotes synapse differentiation at the neuromuscular junction. J. Neurosci. 19 (1999) 7793-7803
95. Turner R.S., Isaac R.E., and Coates D. The neprilysin (NEP) family of zinc metalloendopeptidases: genomics and function. BioEssays 23 (2001) 261-269
96. Warrick J.M., Chan H.Y.E., Gray-Board G.L., Chai Y., Paulson H.L., and Bonini N.M. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat. Genet. 23 (1999) 425-428
97. Warrick J.M., Paulson H.L., Gray-Board G.L., Bui Q.T., Fischbach K.-F., Pittman R.N., and Bonini N.M.w. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell 93 (1998) 939-949
98. Watanabe M., Dykes-Hoberg M., Culotta V.C., Price D.L., Wong P.C., and Rothstein J.D. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues. Neurobiol. Dis. 8 (2001) 933-941
99. Wiedau-Pazos M., Goto J.J., Rabizadeh S., Gralla E.B., Roe J.A., Lee M.K., Valentine J.S., and Bredesen D.E. Altered reactivity of superoxide dismutase in Familial Amyotrophic Lateral Sclerosis. Science 271 (1996) 515-518
100. Wintermeyer P., Kruger R., Kuhn W., Muller T., Woitalla D., Berg D., Becker G., Leroy E., Polymeropoulos M.H., Berger K., Przuntek H., Schols L., Epplen J.T., and Riess O. Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients. Neuro.Rep. 11 (2000) 2079-2082
101. Wittmann C.W., Wszolek M.F., Shulman J.M., Salvaterra P.M., Lewis J., Hutton M., and Feany M.B. Tauopathy in Drosophila: Neurodegeneration without neurofibrillary tangles. Science 293 (2001) 711-714
102. Wong P.C., Pardo C.A., Borchelt D.R., Lee M.K., Copeland N.G., Jenkins N.A., Sisodia S.S., Cleveland D.W., and Price D.L. An adverse property of a Familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14 (1995) 1105-1116
103. Yang Y., Nishimura I., Imai Y., Takahashi R., and Lu B. Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila. Neuron 37 (2003) 911-924
104. Yankner B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16 (1996) 921-932
105. Ye Y., and Fortini M.E. Apoptotic activities of wild-type and Alzheimer's disease-related mutant presenilins in Drosophila melanogaster. J. Cell Biol. 146 (1999) 1351-1364
106. Ye Y., Lukinova N., and Fortini M.E. Neurogenic phenotypes and altered Notch processing in Drosophila presenilin mutants. Nature 398 (1999) 525-529
107. Yim M.B., Kang J.-H., Yim H.-S., Kwak H.-S., Chock P.B., and Stadtman E.R. A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide. Proc. Natl. Acad. Sci. USA 93 (1996) 5709-5714